GGrantIndex
Sort

82,697 grants matching vaccine development

Design and development of generalizable countermeasures against prototype Phenuiviruses

$5,220,489
Amy L Hartman · Washington University · U19 · FY2024 · AI

Preclinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine

$5,220,231
Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2012 · AI

Core D: Antibody Core

$5,212,836
Ali Hassan Ellebedy · Washington University · U19 · FY2024 · AI

HIV Preventive Vaccine and Monoclonal Antibody Studies

$5,211,045
Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

HIV Preventive Vaccine and Monoclonal Antibody Studies

$5,211,045
Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS

$5,208,974
Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA

DEVELOPMENT OF ANTHRAX VACCINE FORMULATIONS

$5,206,725
John Troyer · Pharmathene, Inc. · N01 · FY2014 · AI

Medical Oncology Fellowship Program

$5,199,880
Antonio Fojo · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Mount Sinai IMPACC COVID-19 Cores

$5,198,360
Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2020 · AI

Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network

$5,197,944
Thomas R Fleming · Fred Hutchinson Cancer Research Center · U01 · FY2007 · AI

NIAID Centers of Excellence for Influenza Research and Response

$5,191,617
Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2024 · AI

HIV Monoclonal Antibody Studies

$5,185,063
Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Innovative Platforms for Antimicrobial Therapy and Vaccine Development

$5,183,191
Dennis L. Kasper · Harvard Medical School · U19 · FY2017 · AI

HPV Vaccine Trial

$5,180,080
Allan Hildesheim · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA

VTEU Supplement

$5,179,983
Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2021 · AI

SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER

$5,176,856
John Wayne Cancer Institute · P01 · FY2004 · CA

Malaria Vaccine Production and Support Services

$5,173,244
Kathleen Kootz · Science Applications International Corp · N01 · FY2010 · AI

Advancement of Treatments for Ebola and Marburg Virus Infections

$5,172,726
Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2017 · AI

SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER

$5,170,798
John Wayne Cancer Institute · P01 · FY2002 · CA

EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY

$5,169,515
Marianne Ward · Duke University · N01 · FY2013 · AI

Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses

$5,161,678
Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2021 · AI

COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT

$5,155,276
Barry P Sleckman · University Of Alabama At Birmingham · P30 · FY2021 · CA

EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY

$5,149,999
Thomas N Denny · Duke University · N01 · FY2011 · AI

INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH

$5,147,785
Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2009 · RR

Chemoprophylaxis for HIV Prevention in Men

$5,141,967
Robert M. Grant · J. David Gladstone Institutes · U01 · FY2008 · AI